ETF · Xtrackers
XSHC Xtrackers MSCI USA Health Care UCITS ETF
ISIN IE00BCHWNW54London Stock Exchange: XSHCDeutsche Bank AG
- Healthcare
- ETF
- ISA
- SIPP
- Distributing
Latest close
LSE£56.67
on
- Ongoing charge
- 0.12% a year
- Fund size
- £1.2bn
As of , at least 15 min delayed
At a glance
As of 13/11/2026, XSHC (Xtrackers MSCI USA Health Care UCITS ETF, ISIN IE00BCHWNW54) closed at £56.67 on the London Stock Exchange. Its ongoing charge is 0.12% a year (about £12 on £10,000). Over the five years to 13/11/2026 its total return was +48.3%, or +15.7% after UK CPIH inflation.
Past returns
- 1 year to 13/11/2026
- +23.0%
- +18.7% after inflation (UK CPIH)
- 3 years to 13/11/2026
- +41.3%
- +27.7% after inflation (UK CPIH)
- 5 years to 13/11/2026
- +48.3%
- +15.7% after inflation (UK CPIH)
£1,000 put in five years ago would have been worth about £1,483 on 13/11/2026 — about £1,157 in today’s spending power, once price rises are taken out. Past performance is not a guide to future returns.
Returns: as reported (delayed data). Inflation: UK CPIH, latest month published.
How we work it out:ReturnsReturns after inflationTotal returnReal returnCPIH
Calendar-year and 12-month returns
Calendar-year returns of Xtrackers MSCI USA Health Care UCITS ETF in pounds (price only, income paid out not included): 2022 +6.4%, 2023 −4.8%, 2024 +4.5%, 2025 +3.0%; 2026 to 13/11/2026 +21.5%. Returns of Xtrackers MSCI USA Health Care UCITS ETF in pounds (price only, income paid out not included) over the 12 months to 30/09/2026: +17.6%; to 30/09/2025: −5.6%; to 30/09/2024: +8.5%; to 30/09/2023: −3.9%; to 30/09/2022: +16.5%.
| Year | Return | After inflation | Return shown as a bar |
|---|---|---|---|
| to | +21.5% | +17.7% | |
| to | +3.0% | −0.6% | |
| to | +4.5% | +0.9% | |
| −4.8% | −8.6% | ||
| +6.4% | −2.6% |
| 12 months to | Return | After inflation |
|---|---|---|
| from | +17.6% | +13.4% |
| from | −5.6% | −9.3% |
| from | +8.5% | +5.7% |
| from | −3.9% | −9.7% |
| from | +16.5% | +7.0% |
As of , inflation: UK CPIH
How we work it out:Calendar-year returnsWhat a calendar-year return isAccumulating and distributing
Risk: volatility and largest fall
Volatility (annualised)
14.3%over 5 years
| 1 year | 17.5% |
|---|---|
| 3 years | 14.6% |
| 5 years | 14.3% |
Annualised from weekly returns. Higher means bumpier.
- Largest fall since November 2021
- −19.3%
- From to
- Lowest 12-month return
- −17.2%
- 12 months to
- Highest 12-month return
- +27.5%
- 12 months to
- Below its highest weekly close since November 2021
- 0.0%
- High of , latest
In words: Volatility of Xtrackers MSCI USA Health Care UCITS ETF in pounds, annualised from weekly returns to 13/11/2026: 17.5% over 1 year, 14.6% over 3 years, 14.3% over 5 years. Largest fall in the price of Xtrackers MSCI USA Health Care UCITS ETF since November 2021, in pounds: −19.3% from 31/01/2025 to 23/05/2025. The lowest 12-month return of Xtrackers MSCI USA Health Care UCITS ETF in pounds (price only, income paid out not included) since January 2021 was −17.2% (12 months to 08/08/2025); the highest was +27.5% (12 months to 08/04/2022). On 13/11/2026 the price of Xtrackers MSCI USA Health Care UCITS ETF was at its highest weekly close since November 2021, in pounds.
As of , price only — income paid out is not included
How we work it out:Risk figuresFallsVolatilityLargest fall
Charges compared with similar funds
- Ongoing charge
- 0.12%
- a year
- On £10,000
- £12
- a year, roughly
- Over five years
- £60
- of £10,000, before growth
- 0 charge less
- 0 the same
- 28 charge more
Ongoing charge of Xtrackers MSCI USA Health Care UCITS ETF 0.12% a year. Compared on 14/11/2026, 28 of the 28 other healthcare funds charge more, 0 the same and 0 less (share classes counted once).
As of
A lower charge is not a promise of a higher return: what the fund holds matters more.
Read more:Ongoing charge (OCF)OCF and TERFee dragHow charges add up
In plain English
Xtrackers MSCI USA Health Care UCITS ETF is an exchange-traded fund (ETF) from Xtrackers, launched in 2017.
It tracks the MSCI USA / Health Care -SEC.
You buy and sell it through a share-dealing account or platform during stock-market hours, like a share.
Its ongoing charge is 0.12% a year — about £12 a year on every £10,000 invested, taken from the fund's value rather than billed to you.
Income from its investments is paid out to holders as cash, usually a few times a year.
Healthcare: Pharmaceutical, biotech and medical-equipment companies.
Terms:ETFIndex fundUCITSAccumulating or incomeShare classISIN
Key facts
- Ticker
- XSHC
- ISIN
- IE00BCHWNW54
- Also listed as
- XUHC (London Stock Exchange, US dollars)
- Provider
- Xtrackers
- Tracks
- MSCI USA / Health Care -SEC
- Structure
- ETF
- An exchange-traded fund: bought and sold on the stock exchange through the day, like a share.
- Income
- Distributing, paid semi-annual
- Income is paid out to holders as cash, usually a few times a year.
- Ongoing charge
- 0.12% a year · about £12 on £10,000
- Fund size
- £1.2bn
- Launched
- Domicile
- Ireland
- UK reporting fund status
- Yes — on HMRC’s list of reporting funds (list of )
- Reporting fund since . What reporting fund status means
- Can usually be held in
- ISA and SIPP
- Check with your platform: each decides which funds it offers.
- Currency hedged
- No
- Price currency
- Pounds (GBP)
- Category
- Healthcare
Price chart
Over the last year, the closing price went from £47.03 on 14/11/2025 to £56.67 on 13/11/2026 (+20.5%). The lowest close shown was £42.43 on 08/05/2026 and the highest £56.67 on 13/11/2026.
One close a week. Before 29/07/2026 the closes are from the weekly price history for this listing; from then on, the closing prices we have recorded. Price only — income paid out is not included, so the line can end below the total return above.
As of , at least 15 min delayed
Five years of prices, and after inflation
262 weekly closes, from 12/11/2021 to 13/11/2026. The same history in November 2026 pounds, adjusted with CPIH inflation.
Create a free account to see the 5-year price chart and the after-inflation chart
Sign-up takes an email address. There is no card to enter and nothing to pay.
How we work it out:Prices and returnsNAV and price
What it holds
- Holdings
- 59
- 61 reported in all
- Ten largest
- 60.8%
- of the whole fund
- Effective number of holdings
- 17
- As concentrated as this many equal-sized holdings (how it is worked out)
- Largest holding
- 16.8%
- Eli Lilly
Top 10 holdings
| Rank# | Holding | Weight as a percentage of the fund |
|---|---|---|
| 1 | Eli LillyLLYHealth CareUnited States | 16.75% |
| 2 | Johnson & JohnsonJNJHealth CareUnited States | 10.01% |
| 3 | AbbVieABBVHealth CareUnited States | 7.63% |
| 4 | UnitedHealth GroupUNHHealth CareUnited States | 5.40% |
| 5 | MerckMRKHealth CareUnited States | 5.32% |
| 6 | Thermo Fisher ScientificTMOHealth CareUnited States | 3.81% |
| 7 | AmgenAMGNHealth CareUnited States | 3.70% |
| 8 | Gilead SciencesGILDHealth CareUnited States | 3.06% |
| 9 | Abbott LaboratoriesABTHealth CareUnited States | 2.74% |
| 10 | PfizerPFEHealth CareUnited States | 2.41% |
As of , holdings as published
Where it invests
The portfolio by sector, country and type of asset, as a share of the whole fund. Bonds, cash and positions without a classification are shown as they come, not guessed.
By type of asset
- Equity99.9%
- Cash and money market0.1%
See the full portfolio
Every holding with search and filters, the whole breakdown by sector, country and type of asset, a map of the 59 largest and what changed since .
More of the portfolio
The fund publishes 61 holdings; the ten largest make up 60.8% of it. The fund's portfolio is also split by currency.
Create a free account to see the full holdings list and the currency, maturity and credit-quality breakdowns
Sign-up takes an email address. There is no card to enter and nothing to pay.
Holdings:Compare what it holds with another fundHoldings overlapHow overlap is measured
Risk and return in depth
Sharpe, Sortino and Calmar ratios
Sharpe, Sortino and Calmar ratios over 1, 3 and 5 years, from weekly returns in pounds.
With a free accountRolling returns
The full range of 254 rolling 12-month returns since January 2021, and of 150 rolling three-year returns, in pounds, with how often they were above zero.
With a free accountLargest falls and recoveries
The 3 largest falls since November 2021, in pounds, with how many weeks each took to reach its low and to recover.
With a free account
Create a free account to see the risk ratios, every rolling return and each large fall and its recovery
Sign-up takes an email address. There is no card to enter and nothing to pay.
Moves compared with a similar fund
Correlation and beta of weekly returns in pounds against iShares Core S&P 500 UCITS ETF, over the three years to 13/11/2026 (154 weeks).
Pro
Pro — currently by invitation
Pro includes moves against a comparable fund
Pro is open by invitation while it is being built. There is nothing to buy. To ask about access, email [email protected].
Questions people ask
What is the ongoing charge of XSHC?
The ongoing charge of XSHC is 0.12% a year — about £12 a year on every £10,000 invested, taken from the fund’s value rather than billed to you. Platform and dealing fees are charged separately. Ongoing charge of Xtrackers MSCI USA Health Care UCITS ETF 0.12% a year. Compared on 14/11/2026, 28 of the 28 other healthcare funds charge more, 0 the same and 0 less (share classes counted once).
What does XSHC track?
XSHC tracks the MSCI USA / Health Care -SEC.
Is XSHC accumulating or distributing?
XSHC is distributing: income is paid out to holders as cash, usually a few times a year. It pays out semi-annual.
What is the ISIN of XSHC?
The ISIN of XSHC is IE00BCHWNW54. An ISIN identifies one exact share class of a fund; XSHC is its ticker on the London Stock Exchange. The same share class is also listed as XUHC (London Stock Exchange, US dollars).
What does XSHC hold?
As of 15/11/2026, XSHC holds 61 positions, according to its published holdings. The largest is Eli Lilly at 16.75% of the fund; the ten largest make up 60.8%. Its ten largest holdings are Eli Lilly (16.75%), Johnson & Johnson (10.01%), AbbVie (7.63%), UnitedHealth Group (5.40%), Merck (5.32%), Thermo Fisher Scientific (3.81%), Amgen (3.70%), Gilead Sciences (3.06%), Abbott Laboratories (2.74%) and Pfizer (2.41%).
What were XSHC’s returns in each of the last five years?
Calendar-year returns of XSHC in pounds (price only, income paid out not included): 2022 +6.4%, 2023 −4.8%, 2024 +4.5%, 2025 +3.0%; 2026 to 13/11/2026 +21.5%. Past performance is not a guide to future returns.
How has XSHC done after inflation?
Over the five years to 13/11/2026 XSHC’s total return was +48.3%, or +15.7% after UK CPIH inflation. Past performance is not a guide to future returns.
Similar funds
- XWHSXtrackers MSCI World Health Care UCITS ETF0.25% a year · £3.4bn
- IHCUiShares S&P 500 Health Care Sector UCITS ETF0.15% a year · £2.7bn
- DRDRiShares Healthcare Innovation UCITS ETF0.40% a year · £1.3bn
- BTEKiShares NASDAQ US Biotechnology UCITS ETF0.35% a year · £1.0bn
- CH5Amundi STOXX Europe 600 Healthcare UCITS ETF -Acc- Capitalisation0.30% a year · £833m
- ESIHiShares MSCIEurope Health Care Sector UCITS ETF AccumEUR0.18% a year · £798m
- 0DW6Amundi MSCI World Health Care UCITS ETF EUR ACC0.30% a year · £792m
- AGESiShares Ageing Population UCITS ETF0.40% a year · £677m
Fund documents and methods
- Fund documents
- Fund page at Xtrackers (DWS) (links checked )
Methodology:ReturnsCategoriesAll methods
A machine-readable copy of this page: Markdown.